IS7691A - Lyfjasamsetningar til að meðhöndla æxli - Google Patents
Lyfjasamsetningar til að meðhöndla æxliInfo
- Publication number
- IS7691A IS7691A IS7691A IS7691A IS7691A IS 7691 A IS7691 A IS 7691A IS 7691 A IS7691 A IS 7691A IS 7691 A IS7691 A IS 7691A IS 7691 A IS7691 A IS 7691A
- Authority
- IS
- Iceland
- Prior art keywords
- tumors
- treatment
- drug formulations
- formulations
- drug
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000013583 drug formulation Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39523302P | 2002-07-11 | 2002-07-11 | |
| PCT/US2003/021803 WO2004006842A2 (en) | 2002-07-11 | 2003-07-11 | Combinations of drugs for the treatment of neoplasms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS7691A true IS7691A (is) | 2005-02-09 |
Family
ID=30115841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS7691A IS7691A (is) | 2002-07-11 | 2005-02-09 | Lyfjasamsetningar til að meðhöndla æxli |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20040116407A1 (is) |
| EP (1) | EP1545544A2 (is) |
| JP (1) | JP2005536509A (is) |
| CN (1) | CN1681511A (is) |
| AU (1) | AU2003256511A1 (is) |
| BR (1) | BR0312597A (is) |
| CA (1) | CA2492059A1 (is) |
| HR (1) | HRP20050115A2 (is) |
| IL (1) | IL166217A0 (is) |
| IS (1) | IS7691A (is) |
| MX (1) | MXPA05000485A (is) |
| NO (1) | NO20050204L (is) |
| RU (1) | RU2005103610A (is) |
| WO (1) | WO2004006842A2 (is) |
| ZA (1) | ZA200500618B (is) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6569853B1 (en) * | 2000-11-06 | 2003-05-27 | Combinatorx, Incorporated | Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders |
| FR2842423B1 (fr) * | 2002-07-18 | 2005-07-08 | Centre Nat Rech Scient | Composes a activite anti-parasitaire et medicaments les renfermant |
| US7189740B2 (en) * | 2002-10-15 | 2007-03-13 | Celgene Corporation | Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes |
| CA2517802A1 (en) * | 2003-03-03 | 2004-09-16 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Protein tyrosine phosphatase-prl-1 a a marker and therapeutic target for pancreatic cancer |
| US20050054708A1 (en) * | 2003-07-28 | 2005-03-10 | Nichols Matthew James | Combinations of drugs for the treatment of neoplasms |
| AR047938A1 (es) * | 2003-08-25 | 2006-03-15 | Combinatorx Inc | Formulaciones, conjugados y combinaciones de farmacos para el tratamiento de neoplasmas |
| CN102349927A (zh) * | 2003-08-29 | 2012-02-15 | Hdac默克研究有限责任公司 | 联合治疗癌症的方法 |
| JP2007505914A (ja) * | 2003-09-18 | 2007-03-15 | コンビナトアールエックス インコーポレーティッド | 新生物の治療のための薬物の併用方法 |
| US20050158320A1 (en) * | 2003-11-12 | 2005-07-21 | Nichols M. J. | Combinations for the treatment of proliferative diseases |
| US20050100508A1 (en) * | 2003-11-12 | 2005-05-12 | Nichols M. J. | Methods for identifying drug combinations for the treatment of proliferative diseases |
| WO2005051296A2 (en) * | 2003-11-24 | 2005-06-09 | University Of North Carolina At Chapel Hill | Fused ring dicationic anti-protozoan agents and their prodrugs |
| US7510710B2 (en) | 2004-01-08 | 2009-03-31 | The Regents Of The University Of Colorado | Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor |
| AU2005316652B2 (en) * | 2004-12-15 | 2009-07-23 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Combinations of therapeutic agents for treating cancer |
| TW200719903A (en) * | 2005-04-19 | 2007-06-01 | Combinatorx Inc | Compositions for the treatment of neoplasms |
| CA2611735A1 (en) * | 2005-04-28 | 2006-11-02 | The Regents Of The University Of Colorado | Therapeutic bifunctional compounds |
| WO2006118821A2 (en) * | 2005-05-02 | 2006-11-09 | The Regents Of The University Of Colorado | Systems and methods for treating human inflammatory and proliferative diseases, with a combination of compounds, or a bifunctional compound,that provides fatty acid metabolism and glycolysis inhibition |
| TW200716141A (en) * | 2005-05-05 | 2007-05-01 | Combinatorx Inc | Compositions and methods for treatment for neoplasms |
| CA2630334C (en) * | 2005-11-16 | 2013-07-23 | Universidad Nacional Autonoma De Mexico | Use of transcriptome-modifying agents and chemotherapy or radiotherapy against cancer |
| WO2008016890A1 (en) * | 2006-07-31 | 2008-02-07 | Abbott Laboratories | Antitumorigenic drug combination |
| WO2009029656A1 (en) * | 2007-08-27 | 2009-03-05 | Auxagen, Inc. | METHODS FOR INHIBITING TGF-β |
| US8394377B2 (en) * | 2008-02-21 | 2013-03-12 | The Regents Of The University Of Colorado | Methods for treating cancer using combination therapy |
| WO2010008554A2 (en) | 2008-07-14 | 2010-01-21 | The Regents Of The University Of Colorado | Methods and products for treating proliferative diseases |
| WO2010033507A1 (en) | 2008-09-16 | 2010-03-25 | St. Louis University | Method of enhancing tgf-beta signalling |
| RU2519200C2 (ru) * | 2008-10-01 | 2014-06-10 | Новартис Аг | Применение антагонистов smoothened для лечения связанных с путем hedgehog нарушений |
| CA2758856A1 (en) * | 2009-05-01 | 2010-11-04 | Oncozyme Pharma Inc. | Pentamidine combinations for treating cancer |
| ITRM20090578A1 (it) * | 2009-11-10 | 2011-05-11 | Noi Per Voi Onlus | Nuove composizioni per il trattamento di leucemie chemioresistenti e/o di leucemie potenzialmente chemioresistenti. |
| US8809299B2 (en) * | 2012-03-28 | 2014-08-19 | Mcmaster University | Combination therapy for the treatment of cancer |
| CN105030785B (zh) * | 2015-06-30 | 2017-11-10 | 上海交通大学 | Promethazine在制备抗肝癌和/或结肠癌和/或肺癌产品中的应用 |
| PL3789029T3 (pl) * | 2018-05-04 | 2024-07-15 | Korea Institute Of Radiological & Medical Sciences | Kompozycja zwiększająca wrażliwość na promieniowanie zawierająca arypiprazol jako składnik aktywny |
| CN113264925A (zh) * | 2020-02-14 | 2021-08-17 | 上海美悦生物科技发展有限公司 | 一种杂环化合物及其制备方法和用途 |
| CN113304155B (zh) * | 2021-05-24 | 2023-03-24 | 四川大学华西医院 | 一种抗肿瘤的药物组合物及其制备方法和用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2645640A (en) * | 1953-07-14 | Phenthiazine derivatives | ||
| DE3827974A1 (de) * | 1988-08-18 | 1990-02-22 | Boehringer Mannheim Gmbh | Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen |
| US6569853B1 (en) * | 2000-11-06 | 2003-05-27 | Combinatorx, Incorporated | Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders |
-
2003
- 2003-07-11 CA CA002492059A patent/CA2492059A1/en not_active Abandoned
- 2003-07-11 CN CNA038211513A patent/CN1681511A/zh active Pending
- 2003-07-11 BR BR0312597-1A patent/BR0312597A/pt not_active IP Right Cessation
- 2003-07-11 MX MXPA05000485A patent/MXPA05000485A/es not_active Application Discontinuation
- 2003-07-11 WO PCT/US2003/021803 patent/WO2004006842A2/en not_active Ceased
- 2003-07-11 EP EP03764557A patent/EP1545544A2/en not_active Withdrawn
- 2003-07-11 RU RU2005103610/14A patent/RU2005103610A/ru not_active Application Discontinuation
- 2003-07-11 US US10/617,424 patent/US20040116407A1/en not_active Abandoned
- 2003-07-11 HR HR20050115A patent/HRP20050115A2/hr not_active Application Discontinuation
- 2003-07-11 AU AU2003256511A patent/AU2003256511A1/en not_active Abandoned
- 2003-07-11 JP JP2004521730A patent/JP2005536509A/ja not_active Withdrawn
-
2005
- 2005-01-10 IL IL16621705A patent/IL166217A0/xx unknown
- 2005-01-13 NO NO20050204A patent/NO20050204L/no not_active Application Discontinuation
- 2005-01-21 ZA ZA200500618A patent/ZA200500618B/xx unknown
- 2005-02-09 IS IS7691A patent/IS7691A/is unknown
-
2006
- 2006-10-24 US US11/585,486 patent/US20070099905A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005536509A (ja) | 2005-12-02 |
| IL166217A0 (en) | 2006-01-15 |
| HRP20050115A2 (en) | 2005-10-31 |
| WO2004006842A2 (en) | 2004-01-22 |
| CN1681511A (zh) | 2005-10-12 |
| ZA200500618B (en) | 2006-08-30 |
| EP1545544A2 (en) | 2005-06-29 |
| BR0312597A (pt) | 2005-05-10 |
| WO2004006842A3 (en) | 2004-05-27 |
| US20070099905A1 (en) | 2007-05-03 |
| US20040116407A1 (en) | 2004-06-17 |
| AU2003256511A1 (en) | 2004-02-02 |
| NO20050204L (no) | 2005-04-08 |
| MXPA05000485A (es) | 2005-04-19 |
| CA2492059A1 (en) | 2004-01-22 |
| RU2005103610A (ru) | 2005-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS8398A (is) | Lyfjasamsetningar til að meðhöndla æxli | |
| IS7691A (is) | Lyfjasamsetningar til að meðhöndla æxli | |
| CY2013022I1 (el) | Συνθεσεις για την θεραπευτικη αγωγη γαστρεντερικων διαταραχων | |
| NO20053077D0 (no) | Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer. | |
| CY2015003I1 (el) | Φαρμακευτικες συνθεσεις για θεραπεια καρκινου | |
| IS8142A (is) | Læknislyf gagnleg til meðferðar á verkjum | |
| NO20052894D0 (no) | 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte | |
| PT1501534E (pt) | Formulacoes farmaceuticas | |
| NO20044054L (no) | Administrering av midler for behandling av betennelse | |
| NO20052914D0 (no) | Terapeutiske forbindelser | |
| DK1499730T3 (da) | Immunokonjugater til behandling af tumorer | |
| IS7670A (is) | Samsett meðferð fyrir offjölgunar sjúkdóma | |
| DK1446012T3 (da) | Bakteriolytisk kombinationsterapi til behandling af tumorer | |
| IS8125A (is) | Kínasólínafleiður til að meðhöndla krabbamein | |
| CY2018006I2 (el) | Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας | |
| IS6917A (is) | Epóþílon afleiður til meðhöndlunar erfiðra æxla | |
| NO20024775D0 (no) | Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
| ITMI20031311A0 (it) | Formulazioni per il trattamento di disturbi artrosici | |
| IL175535A (en) | Compositions for treatment of neurodegenerative diseases | |
| NO20045554L (no) | Fremgangsmate for behandling av diabetes | |
| EP1570270A4 (en) | THERAPEUTIC BIOKON JUGATE | |
| NO20033804D0 (no) | Karbamatforbindelser for behandling av smerte | |
| NO20043576L (no) | Pharmaceutical formulation comprising melatonin | |
| DK1553950T3 (da) | Terapeutisk behandling | |
| DK1567524T3 (da) | Thia-epothilonderivater til behandling af cancer |